Biopolymer-encapsulated enzyme formulations for cold-water and low-water detergent applications

Technology
In development
Company

Lytos Technologies offers alginate-encapsulated, engineered enzyme formulations that release active cleaning ingredients on demand at temperatures as low as 4°C and under low-water conditions. Compatible with amylase, lipase, and other detergent actives, these GRAS biopolymer systems are safe, certifiable organic, and ready for whitening and odor-removal performance validation.

Overview

Lytos Technologies is developing biopolymer-encapsulated enzyme formulations designed to deliver active cleaning ingredients in cold-water and low-water laundry and cleaning applications. The technology builds on the company's proprietary LytosBI platform and its established expertise in engineering polysaccharide-degrading enzymes, including alginate-degrading enzymes that are already being commercialized for crop protection through Lytos's commercial operations.

The core value proposition is temperature- and condition-dependent release of enzymes from alginate and other GRAS (Generally Recognized as Safe) biopolymer films. By tuning the biopolymer composition and the engineered enzyme, formulations can be activated across a broad range from 4°C to 55°C, enabling effective cleaning performance under conditions where conventional detergent enzymes are inactive or underperforming. These formulations have already passed toxicology testing for EPA registration and are eligible for OMRI organic certification, making them attractive for sustainable product lines.

Technical specifications

Key features:

  • Alginate and GRAS biopolymer encapsulation that protects enzymes during storage and controls release rate upon exposure to water
  • Engineered alginate-degrading enzymes designed for temperature-dependent activation, enabling activity from 4°C to 55°C
  • Compatibility with common detergent actives including amylase, lipase, and other enzymes, allowing co-formulation in existing detergent products
  • Demonstrated antimicrobial activity against a range of microbes in high-bioburden conditions and validated removal of bound material from surfaces in real-world settings
  • GRAS biopolymer composition that is safe for use and eligible for organic certification
  • Scalable, cost-effective manufacturing process already established at commercial scale

How it works:

The encapsulated enzyme system uses a biopolymer shell that dissolves or degrades under specific environmental conditions. By engineering the enzyme's degradation kinetics as a function of biopolymer type, temperature, and additives, the team can tailor the release profile to match the target application. Published research from the group describes how enzyme activity and degradation rate can be modulated through biopolymer selection and formulation additives, informing rational design of release profiles for low-water, low-temperature cleaning scenarios.

Technology readiness level

The underlying enzyme and biopolymer encapsulation technology has been validated through multiple peer-reviewed publications on enzyme engineering, antimicrobial efficacy, and surface cleaning performance. Commercial validation has been achieved through Lytos Technologies, which has completed key EPA toxicology and efficacy testing and established cost-effective, commercial-scale manufacturing for related polysaccharide-degrading enzyme products.

The next stage of validation focuses on three areas: (1) benchmarking whitening and odor-removal performance against published protocols and patent benchmarks, (2) testing dissolution rates of varying alginate/biopolymer ratios at low temperature and high solids loading to optimize temperature-dependent release, and (3) co-formulating with commercial detergent enzymes to confirm synergistic activity. These steps are intended to transition the technology from validated laboratory and adjacent commercial use into detergent-specific applications.


About Lytos Technologies, Inc.

Lytos Technologies is a biosolutions platform company that engineers biology to address persistent challenges across water, food, agriculture, and health sectors. The company utilizes its proprietary LytosBI platform, which integrates computational modeling, data-driven design, and molecular biology, to develop technologies that dismantle biofilms and neutralize microbial pathogens. By focusing on fundamental biological mechanisms, Lytos creates targeted alternatives to traditional chemical approaches, aiming to provide solutions that are safer, more sustainable, and capable of performing in complex real-world environments. The company's core scientific foundation stems from research into novel anti-biofilm enzymes, which allow for the advancement of laboratory-validated innovations into scalable, field-ready biosolutions.

The company collaborates with industry, government, and institutional partners, such as the USDA and the University of Virginia, to translate scientific breakthroughs into practical applications. This partnership-driven approach ensures that their developments meet specific real-world requirements for performance, safety, and deployment. By replacing or enhancing conventional chemical methods with biological intelligence, Lytos seeks to resolve critical issues ranging from crop yield protection and food safety to environmental contamination, helping customers and stakeholders manage risks in diverse operating conditions. Through its efforts, the company aims to foster a healthier and more sustainable future by expanding the capabilities of engineered biology.

Sign up to access the full partnering listing.
View the details of this partnering listing and connect directly with the teams behind promising technologies.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.